Lv3
380 积分 2024-07-23 加入
The conundrum of drug development in higher-risk MDS: lessons learned from recently failed phase 3 clinical trials
23天前
已完结
An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma
23天前
已完结
Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors
23天前
已完结
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis
29天前
已完结
The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial
4个月前
已完结
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
4个月前
已完结
Systemic lupus erythematosus
4个月前
已完结
First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction
4个月前
已完结
Adeno-associated virus vector as a platform for gene therapy delivery
5个月前
已完结
Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus
6个月前
已完结
皖公网安备34019202002308
